beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

Term ID

CHEBI:148542

Synonyms

beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)-D-galacto-hexopyranose
beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-D-galactopyranose
Gal(b1-3)GlcNAc(b1-3)Gal
N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]acetamide

Definition

An amino trisaccharide consisting of β-D-galactopyranose, 2-acetamido-2-deoxy-β-D-glucopyranose and D-galactopyranose residues joined in sequence by (1→3) glycosidic bonds.

References

glygen:G23041XK
glytoucan:G23041XK
kegg.glycan:G00537

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

Phenotype affecting beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-Galp

Human Disease Model